Localized small-bowel infarction caused by Aspergillus during chemotherapy for acute myeloid leukemia: report of a

Megumu Enjoji1, Shunroh Ohtsukasa, Hiroto Nagano

  • 1Department of Surgery, Musashino Red Cross Hospital, Musashino, Tokyo, Japan.

Surgery Today
|June 19, 2008
PubMed

Insights

Invasive aspergillosis, a fungal infection, can cause rare but fatal intestinal complications in chemotherapy patients. This case highlights small-bowel infarction due to Aspergillus in a leukemia patient, emphasizing the need for prompt diagnosis.

Area of Science:

  • Medicine
  • Mycology
  • Gastroenterology

Background:

  • Aspergillosis is a significant opportunistic infection in immunocompromised individuals, particularly those on chemotherapy.
  • The incidence of invasive fungal infections, including aspergillosis, has been rising in recent years.

Observation:

  • A 48-year-old male undergoing chemotherapy for acute myeloid leukemia presented with acute abdominal pain and fever.
  • Imaging revealed a perfusion defect in the ileum, leading to surgical resection.
  • Microscopic examination confirmed Aspergillus invasion of necrotic tissue and blood vessels in the resected small bowel.

Findings:

  • The patient experienced small-bowel infarction secondary to invasive Aspergillus infection.
  • Histopathology demonstrated transmural necrosis and microperforation of the ileum.
  • The patient recovered well post-surgery and was discharged after 14 days.

Implications:

  • Intestinal aspergillosis is a rare but critical diagnosis in neutropenic patients presenting with acute abdominal symptoms.
  • Early consideration of invasive fungal infection is crucial for timely intervention and improved patient outcomes.
  • This case underscores the importance of a high index of suspicion for aspergillosis in immunocompromised patients with gastrointestinal distress.